nawerexcellent.blogg.se

Clearview professional#

We believe GHO, with its strong sector expertise, is uniquely positioned to build on ClearView’s strong track record and reputation. Operating within a highly fragmented market, ClearView is a best-in-class consultancy within the life sciences space. The Partners at GHO Capital, said, “We are delighted to have the opportunity to partner with the ClearView team. The investment follows the announcement of GHO Capital III, in July 2021, with over €2 billion of capital available to invest, the addition of new team hires and the opening of a US office in Research Triangle Park in support of GHO’s network of North American companies. Against a backdrop of industry fragmentation, the company will significantly benefit from GHO’s resources, expertise and global reach in building its European practice and driving geographic expansion via M&A.ĬlearView is set to continue driving significant organic growth, cross selling emerging solutions including data analytics and pricing & market access to expand an existing client base while leveraging relationships to broaden capabilities across the small and mid-cap life sciences. Led by its founders, Rich Mynahan, Steve Chao and Kevin Richard, alongside a world-class leadership team, ClearView is well positioned to enhance its market-leading position within life sciences consulting, an industry exhibiting accelerating secular growth. ClearView services a wide range of market leading innovators across the Big Pharma/Biopharma, Diagnostics, MedTech, and life science services/tools segments.

ClearView supports drug sponsors throughout the development and commercialisation process as well as guides overall approaches to clinical and commercial portfolio development.

Headquartered in Boston and with offices in New York, San Francisco, London and Zurich, ClearView is known for combining its deep and diversified therapeutic expertise with business insights to deliver actionable recommendations to its customers in support of growth and innovation strategy.

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, and the founding partners of ClearView Healthcare Partners, announce a majority recapitalisation of ClearView Healthcare Partners (“ClearView”), the leading life sciences strategic consultancy supporting Pharma and Biotech sponsors globally.

Management to pursue international markets and broaden service offering, leveraging GHO’s unparalleled sector expertise.

ClearView positioned as market leader in an industry experiencing strong tailwinds.

GHO partnering with existing management team to accelerate global growth.

She lives in Hillsborough, NC with her husband (Larry) and enjoys spending time with her grandson (Jaxon) and singing in her church choir. In the role of Member Services Coordinator with ClearView, Julie is responsible for day-to-day servicing of the Alliance Members. In recent years, Julie was the Marketing and Member Services Coordinator for the Advent Users Group(AUG), a national membership organization of more than 325 registered investment advisers. Additionally, she was responsible for Oak Value’s compliance with Global Investment Performance Standards (GIPS®) and for implementing and monitoring the firm’s policy for the internal preparation, presentation, review and approval of all performance information disseminated to the firm’s individual clients and its external performance auditors. She has managed a client accounting and servicing team and managed the investment performance reporting for more than 600 client portfolios (including an SEC-Registered mutual fund). Julie brings a unique set of skills and experiences to ClearView. For 16 of those years, she worked directly with ClearView’s CEO at Oak Value Capital Management, Inc.

Clearview professional#

Julie is a seasoned professional of more than 20 years of experience in the investment industry. In addition to having served on the Boards of several non-profits including the Coastal Educational Foundation and the United Methodist Foundation, he co-managed investment portfolios for more than three dozen foundations, endowments and not-for profit organizations over the last 20 years. Larry earned a BS in Business Administration from Coastal Carolina University in 1981 and an MBA from the University of South Carolina in 1983. He and his partners sold Oak Value to RS Investments LLC of San Francisco in 2010 and remained with that successor firm until the end of 2012. During his 17 year tenure at Oak Value, he rose to the position of Chief Executive and Portfolio Manager. After working as a Senior Consultant with Andersen Consulting (predecessor to Accenture), Larry entered the investment industry where he was an Institutional Representative and investment consultant until he joined Oak Value Capital Management, Inc. Larry has over 30 years of investment and consulting industry experience.